The effect of probiotics on Helicobacter pylori eradication

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2032-2036

  Sung, Keun Park ^a   Dong, Il Park ^a   Joong, Sub Choi ^a   Mun, Su Kang ^a   Jung, Ho Park ^a   Hong, Joo Kim ^a   Yong, Kyun Cho ^a   Chong, Il Sohn ^a   Woo, Kyu Jeon ^a   Byung, Ik Kim ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Eradication; Helicobacter pylori; Probiotics

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACILLUS SUBTILIS; BITTER TASTE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DUODENUM ULCER; DYSPEPSIA; ENTEROCOCCUS FAECALIS; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMACH ULCER;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROBIOTICS;

EID: 37749008840     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Go MF: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16:1-15.
2. Felley C, Michetti P: Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol 2003; 17:785-791.
3. Malfertheiner P, Megraud F, O'Morain C, Hunting APS, Jones R, Axon A, Graham DY, Tytgat G: European Helicobacter pylori study group. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16:167-180.
4. Malfertheiner P, Bayerdorffer E, Diete U, Gil J, Lind T, Misiuna P, O'Morain C, Sipponen P, Spiller RC, Stasiewicz J, Treichel HC, Ujszaszy L, Unge P, Veldhuyzen van Znaten SJO, Zeijlon L: The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 13:703-712.
5. Veldhuyzen Van Zanten SJO, Bradette M, Farley A, Leddin D, Lind T, Unge P, Bayerdörffer E, Spiller RC, Morain CO, Sipponen P, Wrangstadh M, Zeujlon L, Sinclair P: The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13:289-295.
6. Elmer GW, Surawicz CM, McFarland LV: Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996; 275:870-876.
7. Rolfe RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130:396-402.
8. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvert M, Blum AL, Corthesy-Theulaz I: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La 1 on Helicobacter pylori infection in humans. Digestion 1999; 60:203-209.
9. Kabir AMA, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y: Prevention of Helicobacter pylori infection by lacto bacilli in a gnotobiotic murine model. Gut 1997; 41:49-55.
10. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A: The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15:163-169.
11. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A: Effect of Lactobacillus GG supplementation on antibiotic- associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63:1-7.
12. Ouwehand AC, Salminen S, Isolauri E: Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002; 82:279-289.
13. Habermann W, Zimmermann K, Skarabis H, Kunze R, Rusch V: Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin). Arzneimittelforschung 2002; 52:622-627.
14. Hamilton-Miller JM: The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003; 22:360-366.
15. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A: A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14:1625-1629.
16. Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD: Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16:1669-1675.
17. Naidu AS, Bidlack WR, Clemens RA: Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999; 39:13-126.
18. Mercenier A, Pavan S, Pot B: Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9:175-191.
19. Karita M, Li Q, Canero D, Okita K: Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am J Gastroenterol 1994; 89:208-213.
20. Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P: Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13:25-29.
21. Wendakoon CN, Thomson AB, Ozimek L: Lack of therapeutics effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 2002; 65:16-20.
22. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML: In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995; 79:475-479.
23. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y: Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93:2097-2101.
24. Gotz V, Romankiewicz JA, Moss J, Murray HW: Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979; 36:754-757.
25. Siionen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wkikberg R, Kirkkola AL: Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22:57-59.
26. Contardi I: Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood. Clin Ter 1991; 136:409-413.
27. Surawicz CM, Elmer GW, Speelman P, Mc Farland LV, Chinn J, van Belle G: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96:981-988.